TippingPoint Biosciences raised an undisclosed amount in Pre-Seed funding led by Pediatric Brain Tumor Foundation, Sontag Foundation, Yuvaan Tiwari Foundation, and BrightEdge to expand operations and development efforts.
Round Type
Pre-Seed
San FranciscoBiotechnologyHealth CareMedicalTherapeuticsInvestors
Description
TippingPoint Biosciences, a San Francisco-based therapeutic company, has closed a Pre-Seed funding round. The funds will be used to expand operations and further develop its innovative drug discovery platform targeting aberrant DNA in cancer cells.
Quick answer
TippingPoint Biosciences raised an undisclosed amount in a Pre-Seed round, dated September 5, 2024. Investors: Bright Edge, Yuvaan Tiwari Foundation, Sontag Foundation and Pediatric Brain Tumor Foundation. TippingPoint Biosciences is based in San Francisco, California, United States.
- How much did TippingPoint Biosciences raise?
- TippingPoint Biosciences raised an undisclosed amount in a Pre-Seed round on September 5, 2024.
- Who invested in TippingPoint Biosciences?
- Bright Edge, Yuvaan Tiwari Foundation, Sontag Foundation and Pediatric Brain Tumor Foundation are named as investors in this round.
- What does TippingPoint Biosciences do?
- TippingPoint Biosciences is a San Francisco-based therapeutic company focused on innovative drug discovery targeting the aberrant DNA in cancer cells.
- Where is TippingPoint Biosciences based and how big is it?
- TippingPoint Biosciences is based in San Francisco, California, United States.
- Who are the decision-makers at TippingPoint Biosciences?
- Fundz holds 1 contact at TippingPoint Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as TippingPoint Biosciences that raised within 45 days of this round, from Fundz verified event records.
- MONCYTE Health raised $1.1M (Seed) on October 8, 2024.
- CorFlow Therapeutics AG raised $49M (Series B) on September 10, 2024.
- Diakonos Oncology raised $11M (Seed) on August 26, 2024.
- Lipella Pharmaceuticals raised $120K on July 31, 2024.
- Ikerian raised $8M (Series B) on October 16, 2024.
- TenNor Therapeutics raised $41M (Series E) on October 16, 2024.
Who to call at TippingPoint Biosciences, and when
A new round usually means TippingPoint Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TippingPoint Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TippingPoint Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TippingPoint Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TippingPoint Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TippingPoint Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.